Mutual Fund

Fund Card

Mirae Asset Healthcare Fund-Reg(G)

very highequitypharma & health care

31.17 0.34(1.09%) NAV as on 25 Apr 2024

2.05 % 1 M

49.48 % 1 Y

15.56 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

FUND OBJECTIVE

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns.

SCHEME DETAILS

Expenses Ratio :

1.99

As on 31 Mar, 2024

Age :

5 yrs 9 m

Since 02 07 ,2018

Exit Load :

AUM :

2,235.15 Crs

Lock-in :

1% on or before 1Y(365D), Nil after 1Y(365D)

Investing Style :

Large Growth

Portfolio Price To Book Value :

6.45

Min. Investment :

SIP 500 & Lumpsum 5000

Scheme Benchmark :

S&P BSE HEALTH CARE - TRI

Fund Manager :

Vrijesh Kasera

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2024

Others 0.42 %

Equity 99.58 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.92 %

Cipla Ltd.9.62 %

Aurobindo Pharma Ltd.8.25 %

Dr. Reddy's Laboratories Ltd.7.17 %

Apollo Hospitals Enterprise Ltd.6.34 %

See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs	76.53
Hospital & Healthcare Services	17.98
Business Support	1.93
Chemicals	1.78
Finance - Others	1.35

See All Sectors

5-YEARS HISTORY

Financial Year	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
NAV in Rs (as on 31-Mar-2024)	10.59	18.77	22.38	20.12	31.14
Net Assets(Rs Crores) (as on 31-Mar-2024)	378.00	1268.97	1817.47	1513.40	2235.15
Scheme Returns(%)(Absolute)	-0.93	79.31	18.45	-9.89	54.74
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	8/75	27/75	34/75	69/76	23/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Mirae Asset Healthcare Fund-Reg(G)Very HighEquity31.170.34(1.09%)NAV As on 25 Apr, 2024	02-Jul-2018Inception Date	2,235.15AUM In Cr.	49.48%1Y	15.56%3Y	23.76%5Y	21.58%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity30.660.36(1.19%)NAV As on 25 Apr, 2024	13-Jul-2018Inception Date	3,772.32AUM In Cr.	58.94%1Y	17.88%3Y	24.49%5Y	21.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity344.410.76(0.22%)NAV As on 25 Apr, 2024	14-Jul-1999Inception Date	2,626.34AUM In Cr.	54.50%1Y	17.80%3Y	23.16%5Y	16.11%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity32.450.23(0.73%)NAV As on 25 Apr, 2024	30-Nov-2018Inception Date	2,352.32AUM In Cr.	51.82%1Y	16.49%3Y	25.51%5Y	24.33%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity25.050.29(1.19%)NAV As on 25 Apr, 2024	28-Dec-2015Inception Date	878.70AUM In Cr.	53.10%1Y	16.35%3Y	22.08%5Y	11.65%Since Inception
Nippon India Pharma Fund(G)Very HighEquity427.184.56(1.08%)NAV As on 25 Apr, 2024	05-Jun-2004Inception Date	7,125.28AUM In Cr.	52.35%1Y	16.03%3Y	22.67%5Y	20.76%Since Inception